Clinical Trial Update: Neoadjuvant Comprehensive Treatment for Unresectable Esophageal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating neoadjuvant comprehensive treatment for unresectable esophageal cancer; the study is currently recruiting in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Esophagus Cancer | Phase 2 | Status: RECRUITING